कृपया अन्य खोज का प्रयास करें
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted radiotherapies to deliver cancer-killing radiation to treat patients with high unmet medical needs. Its lead product candidate, Iomab-B (I-131 apamistamab) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for bone marrow transplant conditioning; and a Phase I study with a CD19- targeted CAR T-cell therapy with memorial sloan kettering cancer center. The company offers clinical and preclinical development programs that utilize multiple isotopes, including Actinium-225, Iomab-ACT for GeneTx and cell therapy conditioning, Actimab-A (CD33) and CLAG-M, Actimab-A (CD33) and Venetoclax, and Actimab-A (CD33) and Venetoclax with HMA. It has collaboration with Astellas Pharma, Inc. to develop theranostics for solid tumor indications; EpicentRx, Inc that focuses on a novel CD47 -SIRPa immunotherapy targeted radiotherapy; AVEO Oncology that focuses on developing a HER3 targeting ARC for solid tumors; and Immedica pharma for licensed the rights to commercialize Iomab-B. The company is based in New York, New York.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Elihu H. Estey | - | - | Member of Clinical Advisory Board |
Sandesh C. Seth | 60 | 2012 | Chairman & CEO |
Sergio Giralt | - | 2014 | Member of Scientific Advisory Board |
David Colcher | - | 2018 | Members of Nuclear Medicine Clinical Advisory Board |
David A. Scheinberg | 68 | - | Member of Clinical Advisory Board |
Franklin Wong | - | 2018 | Members of Nuclear Medicine Clinical Advisory Board |
Hagop M. Kantarjian | - | - | Member of Clinical Advisory Board |
Jeffrey W. Chell | 70 | 2018 | Independent Director |
Johannes Czernin | - | 2018 | Members of Nuclear Medicine Clinical Advisory Board |
Alexander Perl | - | - | Member of Clinical Advisory Board |
Hillard M. Lazarus | - | 2014 | Member of Scientific Advisory Board |
C. David Nicholson | 69 | 2008 | Lead Independent Director |
Richard E. Champlin | - | 2014 | Member of Scientific Advisory Board |
Michael Yu | - | 2018 | Members of Nuclear Medicine Clinical Advisory Board |
Dan Pryma | - | 2018 | Members of Nuclear Medicine Clinical Advisory Board |
Ajit S. Shetty | 77 | 2017 | Independent Director |
John M. Pagel | - | - | Chairman of Scientific Advisory Board & Member of Clinical Advisory Board |
Richard L. Wahl | - | - | Member of Clinical Advisory Board |
Joseph G. Jurcic | - | - | Chairman of Clinical Advisory Board |
Richard M. Stone | - | 2017 | Member of Scientific Advisory Board |
M. Yair Levy | - | 2014 | Member of Scientific Advisory Board |
Richard I. Steinhart | 67 | 2013 | Independent Director |
Ghassan El-Haddad | - | 2018 | Members of Nuclear Medicine Clinical Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है